Contrast Enhanced Mammography Market Size, Share, Growth Analysis, By Applications(Screening and Diagnosis), By End User(Hospital, Diagnostic Centres, Specialty Clinics, Others), By Region - Industry Forecast 2025-2032

Contrast Enhanced Mammography Market Drivers

• The major factor driving the market growth is rising incidence of breast cancer. Breast cancer is the most common cancer among women worldwide. It is possible to treat breast cancer extremely effectively, especially if the disease is diagnosed early. A breast cancer patient is generally treated with surgery, radiation therapy, and medications (hormone therapy, chemotherapy, and/or targeted biological therapy) to treat the microscopic cancer that has spread from the breast tumor. Treatments such as these can prevent cancer growth and spread, thereby saving lives.

• According to World Health Organization (WHO) 685 000 people worldwide died in 2020 as a result of breast cancer, which affected 2.3 million women. The most common cancer in the globe as of the end of 2020 was breast cancer, which had been diagnosed in 7.8 million women in the previous five years. Worldwide, breast cancer causes more lost disability-adjusted life years (DALYs) for women than any other type of cancer. Every country in the globe experiences breast cancer in women after puberty at any age, albeit the incidence rates rise as people age. Also, merely gender (female) and age, the only known risk factors for breast cancer in women, account for almost half of all cases (over 40 years). Ageing, obesity, drinking too much alcohol, radiation exposure history, family history of breast cancer, reproductive history (such as age at first pregnancy and age at first menstruation), smoking, and postmenopausal hormone therapy are some variables that raise the risk of breast cancer. However, even if all of the possibly controllable risk factors could be avoided, the risk of developing breast cancer would only be decreased by a maximum of 30%. Thus, increasing prevalence of breast cancer is increasing the demand for Contrast Enhanced Mammography, in turn driving the market.

Contrast Enhanced Mammography Market Restraints

• Contrast-enhanced mammography is a relatively new technology, and its cost is higher than traditional mammography. The high cost of equipment, materials, and training needed for contrast-enhanced mammography can be a significant barrier to its adoption. Also, Contrast-enhanced mammography is not widely available, and the number of facilities that offer this technology is still limited. This can make it challenging for patients to access this type of imaging, particularly in rural or remote areas. Moreover, regulatory approval is required before contrast-enhanced mammography can be used in clinical practice. This approval process can be lengthy and expensive, and may delay the introduction of this technology to the market. In addition, although contrast-enhanced mammography has shown promising results in clinical studies, there is still a lack of long-term data on its effectiveness and safety. This can make some healthcare providers hesitant to adopt this technology until more evidence is available.